HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Ochiai Selected Research

asparagine synthetase (glutamine-hydrolyzing)

7/2022Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Ochiai Research Topics

Disease

185Neoplasms (Cancer)
04/2024 - 01/2002
38Neoplasm Metastasis (Metastasis)
10/2023 - 03/2002
31Stomach Neoplasms (Stomach Cancer)
08/2023 - 01/2004
22Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2002
22Adenocarcinoma
01/2020 - 03/2002
20Adenocarcinoma of Lung
10/2019 - 11/2004
18Prostatic Neoplasms (Prostate Cancer)
01/2023 - 05/2003
17Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 03/2002
14Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2003
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 03/2004
13Carcinoma (Carcinomatosis)
02/2019 - 10/2002
12Breast Neoplasms (Breast Cancer)
01/2015 - 03/2004
10Carcinogenesis
05/2019 - 08/2004
9Lung Neoplasms (Lung Cancer)
03/2024 - 01/2004
9Rectal Neoplasms (Rectal Cancer)
09/2022 - 12/2009
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2019 - 10/2003
8Lymphatic Metastasis
07/2015 - 01/2005
6Residual Neoplasm
03/2018 - 01/2005
5Hypoxia (Hypoxemia)
05/2019 - 06/2009
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2023 - 07/2009
4Pain (Aches)
01/2018 - 05/2004
4Adenoma (Adenomas)
01/2018 - 01/2003
4Esophageal Squamous Cell Carcinoma
11/2017 - 06/2006
4Polyps
10/2017 - 10/2002
3Malignant Mesothelioma
01/2021 - 03/2005
3Esophageal Neoplasms (Esophageal Cancer)
02/2010 - 01/2002

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2004
21Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2002
18Cadherins (E-Cadherin)IBA
01/2021 - 01/2004
17ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2002
12Prostate-Specific Antigen (Semenogelase)IBA
04/2015 - 06/2004
10Formaldehyde (Formol)FDA Link
04/2024 - 01/2002
10KalininIBA
07/2019 - 01/2004
10Insulin-Like PeptidesIBA
02/2010 - 01/2004
9ParaffinIBA
04/2024 - 12/2003
9LigandsIBA
08/2023 - 09/2004
9AntibodiesIBA
05/2019 - 03/2005
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2002
8Messenger RNA (mRNA)IBA
12/2022 - 11/2003
8Carbonic Anhydrase IXIBA
01/2021 - 11/2005
7CytokinesIBA
01/2021 - 10/2010
7GemininIBA
02/2019 - 06/2010
7ezrinIBA
01/2018 - 03/2015
6human ERBB2 proteinIBA
06/2022 - 01/2014
6Tyrosine Kinase InhibitorsIBA
01/2021 - 10/2013
6Small Interfering RNA (siRNA)IBA
03/2019 - 04/2008
5Interleukin-6 (Interleukin 6)IBA
10/2023 - 10/2010
5EnzymesIBA
09/2023 - 08/2006
5Thymidylate SynthaseIBA
01/2021 - 01/2002
5Conditioned Culture MediaIBA
12/2020 - 01/2014
5DNA (Deoxyribonucleic Acid)IBA
05/2019 - 03/2004
5Indicators and Reagents (Reagents)IBA
02/2019 - 11/2003
5PlatinumIBA
07/2015 - 03/2004
5Trastuzumab (Herceptin)FDA Link
07/2015 - 05/2011
5beta CateninIBA
09/2010 - 01/2004
5Neutralizing AntibodiesIBA
02/2010 - 05/2005
5Insulin-Like Growth Factor II (Somatomedin A)IBA
02/2010 - 09/2004
4Epidermal Growth Factor (EGF)IBA
02/2024 - 11/2012
4Monoclonal AntibodiesIBA
10/2023 - 01/2006
4Amino AcidsFDA Link
07/2022 - 10/2007
4Glucose (Dextrose)FDA LinkGeneric
07/2022 - 09/2004
4CateninsIBA
07/2022 - 04/2011
4Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 09/2008
4Cisplatin (Platino)FDA LinkGeneric
10/2019 - 01/2002
4Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2019 - 10/2009
4Estrogen ReceptorsIBA
11/2018 - 05/2002
4Phosphotransferases (Kinase)IBA
12/2015 - 05/2003
4Fluorouracil (Carac)FDA LinkGeneric
07/2015 - 01/2002
4Matrix Metalloproteinases (MMPs)IBA
12/2013 - 06/2005
4Insulin-Like Growth Factor I (IGF-1)IBA
02/2010 - 01/2004
3Panitumumab (Vectibix)FDA Link
02/2024 - 01/2017
3Bevacizumab (Avastin)FDA Link
02/2024 - 01/2017
3C-Reactive ProteinIBA
01/2024 - 07/2015
3NucleotidesIBA
09/2023 - 06/2009
3B7-H1 AntigenIBA
08/2023 - 01/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 04/2017
3Calcibiotic Root Canal SealerIBA
01/2021 - 12/2004
3VimentinIBA
01/2021 - 08/2003
3Collagen Type I (Type I Collagen)IBA
01/2020 - 05/2005
3CollagenIBA
02/2019 - 08/2015
3Lactic Acid (Lactate)FDA LinkGeneric
01/2019 - 06/2009
3Gefitinib (Iressa)FDA Link
01/2017 - 11/2004
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2015 - 01/2002
3Oxygen (Dioxygen)IBA
01/2014 - 09/2008
3Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2013 - 01/2004
3Tyrosine (L-Tyrosine)FDA Link
11/2012 - 05/2003
3Histones (Histone)IBA
01/2012 - 04/2008
3IGF Type 1 Receptor (IGF 1 Receptor)IBA
02/2010 - 01/2004
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2009 - 03/2004

Therapy/Procedure

34Therapeutics
03/2024 - 05/2003
27Drug Therapy (Chemotherapy)
02/2024 - 03/2004
14Chemoradiotherapy
08/2021 - 01/2002
9Neoadjuvant Therapy
03/2018 - 12/2005
7Adjuvant Chemotherapy
08/2023 - 12/2008
6Prostatectomy (Retropubic Prostatectomy)
04/2008 - 06/2004
5Radiotherapy
01/2010 - 12/2003
4Gastrectomy
08/2023 - 01/2004
4Lymph Node Excision (Lymph Node Dissection)
01/2016 - 01/2002
3Metastasectomy
05/2019 - 01/2005
3Pancreaticoduodenectomy
04/2015 - 09/2008